Caliber Wealth Management LLC KS bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm bought 7,212 shares of the healthcare conglomerate's stock, valued at approximately $3,778,000.
Other large investors also recently added to or reduced their stakes in the company. Neo Ivy Capital Management purchased a new position in shares of UnitedHealth Group in the first quarter valued at about $557,000. Assetmark Inc. increased its position in shares of UnitedHealth Group by 2.9% in the first quarter. Assetmark Inc. now owns 139,891 shares of the healthcare conglomerate's stock valued at $73,268,000 after acquiring an additional 3,955 shares during the period. USAdvisors Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the first quarter valued at about $223,000. ANB Bank increased its position in shares of UnitedHealth Group by 2.0% during the first quarter. ANB Bank now owns 4,575 shares of the healthcare conglomerate's stock valued at $2,396,000 after buying an additional 90 shares during the period. Finally, Ted Buchan & Co increased its position in shares of UnitedHealth Group by 4.0% during the first quarter. Ted Buchan & Co now owns 5,900 shares of the healthcare conglomerate's stock valued at $3,090,000 after buying an additional 229 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
UNH stock traded up $2.11 during trading on Friday, reaching $280.69. The company had a trading volume of 16,445,593 shares, compared to its average volume of 12,350,532. The firm has a 50-day simple moving average of $301.58 and a 200-day simple moving average of $425.60. The company has a market cap of $254.62 billion, a price-to-earnings ratio of 11.75, a price-to-earnings-growth ratio of 1.38 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.15%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on UNH shares. Piper Sandler reduced their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research report on Tuesday, June 3rd. KeyCorp reduced their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. HSBC reissued a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Truist Financial dropped their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research note on Wednesday, July 16th. Finally, Mizuho dropped their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $392.29.
Read Our Latest Stock Report on UnitedHealth Group
Insider Buying and Selling at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.